|
Table of Contents
TOPICAL STEROID POTENCY
| Topical steroid preparations are grouped according to relative
anti-inflammatory activity, but activity may vary considerably
depending upon the vehicle, the site of application, disease, the
individual patient and whether or not an occlusive dressing is used. |
|
Relative Potency |
Generic Name |
Brand Name |
Strength |
|
Low Potency |
Hydrocortisone1 |
Cortate®, Unicort®, Cortisporin®1,2 |
0.5%, 1% |
|
Medium Potency |
Betamethasone valerate1 |
Betnovate®,
Celestoderm® |
0.05%, 0.1% |
|
Clobetasone-17-butyrate |
Eumovate® |
0.05% |
|
Flucinonide |
Lidex®, Lidemol® |
0.01%, 0.05% |
|
Fluocinolone acetonide |
Synalar®, Synamol®,
Derma-Smooth®1 |
0.01%, 0.025%
0.01%
|
|
Triamcinolone
acetonide1 |
Aristocort D®,
Aristocort R®1,
Kenalog®1,
Vicoderm-KC®1,3 |
0.025%
0.1% |
|
High Potency |
Betamethasone-17-benzoate |
Beben® |
0.025% |
|
Betamethasone
dipropionate |
Propaderm®
Diprosone®,
Diprolene Glycol® |
0.025%
0.05% |
|
Halcinonide |
Halog® |
0.1% |
|
Triamcinolone
acetonide |
Aristocort C® |
0.5% |
|
Highest Potency |
Clobetasol-17-propionate1 |
Dermovate® |
0.05% |
1 formulary drug at VHHSC
2 contains also neomycin
3 contains also neomycin, gramicidin, nystatin
|